title: Novel aryl substituted bicyclic furo nucleosides as extremely potent and selective anti-VZV agents.
authors.affiliation: Welsh School of Pharmacy, Cardiff University, King Edward VII Avenue, Cardiff, CF1 3XF, U.K.
authors.forename: C
authors.initials: C
authors.lastname: McGuigan
authors.forename: H
authors.initials: H
authors.lastname: Barucki
authors.forename: A
authors.initials: A
authors.lastname: Carangio
authors.forename: S
authors.initials: S
authors.lastname: Blewett
authors.forename: S
authors.initials: S
authors.lastname: Srinivasan
authors.forename: G
authors.initials: G
authors.lastname: Andrei
authors.forename: R
authors.initials: R
authors.lastname: Snoeck
authors.forename: E
authors.initials: E
authors.lastname: De Clercq
authors.forename: J
authors.initials: J
authors.lastname: Balzarini
mesh_terms: D000998:Antiviral Agents / Q000138:chemical synthesis* / Q000494:pharmacology*; D001087:Arabinonucleosides / Q000138:chemical synthesis* / Q000494:pharmacology*; D019086:Bridged Bicyclo Compounds, Heterocyclic / Q000138:chemical synthesis / Q000494:pharmacology; D002478:Cells, Cultured; D005347:Fibroblasts / Q000821:virology; D014645:Herpesvirus 3, Human / Q000187:drug effects*; D006801:Humans; D011741:Pyrimidine Nucleosides / Q000138:chemical synthesis* / Q000494:pharmacology*
chemical_list: D000998:Antiviral Agents; D001087:Arabinonucleosides; D019086:Bridged Bicyclo Compounds, Heterocyclic; D011741:Pyrimidine Nucleosides